Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)Yihebali Chi, Jianqiang Cai, Yongqian Shu et al.|The Oncologist|2021Cited by 64
ALDH2 as an immunological and prognostic biomarker: Insights from pan-cancer analysisXiao-Rong Shen, Ligao Wu, Yuan‐Li Huang et al.|Medicine|2024Cited by 3
NEXN targeting MYOCD by facilitating EMT-related β-catenin nuclear translocation modulates the metastasis of hepatocellular carcinomaQiong Wu, Qinghua Yao, Bo Zhang et al.|iScience|2025Cited by 0